ArticleJournal of endocrinological investigation2022

Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors.

R Rodia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.